JNANA THERAPEUTICS Trademark

Trademark Overview

On Friday, June 25, 2021, a trademark application was filed for JNANA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the JNANA THERAPEUTICS trademark a serial number of 90795552. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Monday, November 25, 2024. This trademark is owned by Jnana Therapeutics Inc.. The JNANA THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations that modulate historically undruggable targets across target classes, namely, solute carrier (SLC) metabolite transporters, transcription factors, signaling scaffolds and phosphatases for the treatment of rare, autoimmune and inflammatory diseases and cancer
jnana therapeutics

General Information

Serial Number90795552
Word MarkJNANA THERAPEUTICS
Filing DateFriday, June 25, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateMonday, November 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 8, 2022

Trademark Statements

Description of MarkThe mark consists of the word "Jnana" in a lowercase stylized font with a line over every letter besides "n" with the word "Therapeutics" directly below to the right.
Goods and ServicesPharmaceutical preparations that modulate historically undruggable targets across target classes, namely, solute carrier (SLC) metabolite transporters, transcription factors, signaling scaffolds and phosphatases for the treatment of rare, autoimmune and inflammatory diseases and cancer
NOT AVAILABLE"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 6, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJnana Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameJnana Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events

Event DateEvent Description
Thursday, March 31, 2022NON-FINAL ACTION WRITTEN
Tuesday, June 29, 2021NEW APPLICATION ENTERED
Thursday, September 9, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 10, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, March 17, 2022ASSIGNED TO EXAMINER
Thursday, March 31, 2022NON-FINAL ACTION E-MAILED
Saturday, October 1, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 31, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 30, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 30, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 6, 2022EXAMINERS AMENDMENT -WRITTEN
Thursday, October 6, 2022EXAMINERS AMENDMENT E-MAILED
Thursday, October 6, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, October 6, 2022EXAMINER'S AMENDMENT ENTERED
Thursday, October 6, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 19, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 8, 2022PUBLISHED FOR OPPOSITION
Tuesday, November 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 3, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, June 29, 2023SOU TEAS EXTENSION RECEIVED
Thursday, June 29, 2023TEAS REQUEST TO DIVIDE RECEIVED
Thursday, June 29, 2023DIVISIONAL REQUEST RECEIVED
Thursday, June 29, 2023SOU EXTENSION 1 FILED
Thursday, July 20, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, July 20, 2023DIVISIONAL PROCESSING COMPLETE
Thursday, July 20, 2023SOU EXTENSION 1 GRANTED
Thursday, December 7, 2023SOU TEAS EXTENSION RECEIVED
Saturday, December 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 21, 2023CORRECTED NOA E-MAILED
Friday, July 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 7, 2023SOU EXTENSION 2 FILED
Thursday, December 7, 2023SOU EXTENSION 2 GRANTED
Friday, June 21, 2024SOU TEAS EXTENSION RECEIVED
Friday, June 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 21, 2024SOU EXTENSION 3 FILED
Friday, June 21, 2024SOU EXTENSION 3 GRANTED
Monday, November 25, 2024SOU EXTENSION 4 FILED
Monday, November 25, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, November 26, 2024SOU EXTENSION 4 GRANTED
Tuesday, November 26, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

therapeutics jnana scaffolds phosphatases signaling factors transcription treatment rare cancer diseases inflammatory